Luis Puig

126PUBLICATIONS
183CO-AUTHORS
Molecular targetsDisease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (126)

|Aug 10, 2026
Targeted therapies for psoriasis and atopic dermatitis in the context of malignancy: SPIN-FRT recommendations.

|Jul 31, 2026
Effectiveness and Safety of 40 mg Modified-Release Doxycycline for the Treatment of Hidradenitis Suppurativa: A Single-Center Retrospective Observational Study.

|Jun 02, 2026
Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.

|May 26, 2026
Real-World Evidence That As-Needed Dosing with Bimekizumab in Patients with Psoriasis Is Safe and Effective over Time.

|May 21, 2026
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.

|May 14, 2026
Treatment-associated phenotype switching between psoriasis and atopic dermatitis.

Pageof 21

Frequent Collaborators

14 joint publications

Paolo Gisondi

10 joint publications

Tiago Torres

10 joint publications

Helena Iznardo

10 joint publications

Lluís Rusiñol